These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
102 related articles for article (PubMed ID: 24855017)
1. Synergistic effects of leflunomide and benazepril in streptozotocin-induced diabetic nephropathy. Jin H; Piao SG; Jin JZ; Jin YS; Cui ZH; Jin HF; Zheng HL; Li JJ; Jiang YJ; Yang CW; Li C Nephron Exp Nephrol; 2014; 126(3):148-56. PubMed ID: 24855017 [TBL] [Abstract][Full Text] [Related]
2. Combination of leflunomide and benazepril reduces renal injury of diabetic nephropathy rats and inhibits high-glucose induced cell apoptosis through regulation of NF-κB, TGF-β and TRPC6. Li H; Wang Y; Zhou Z; Tian F; Yang H; Yan J Ren Fail; 2019 Nov; 41(1):899-906. PubMed ID: 31552773 [No Abstract] [Full Text] [Related]
3. [Effects of Tangshenling Mixture and benazepril on rats with diabetic nephropathy and its mechanism]. He XL; Li JP; Chen YP; Zhang ZG; Lin WQ; Chen JH Zhong Xi Yi Jie He Xue Bao; 2006 Jan; 4(1):43-7. PubMed ID: 16409969 [TBL] [Abstract][Full Text] [Related]
4. Experimental study of leflunomide on renal protective effect and on inflammatory response of streptozotocin induced diabetic rats. Yu WM; Wang H; Ren XJ; Liu JP; Wang JY Nephrology (Carlton); 2012 May; 17(4):380-9. PubMed ID: 22243699 [TBL] [Abstract][Full Text] [Related]
5. The anti-inflammation effect of Moutan Cortex on advanced glycation end products-induced rat mesangial cells dysfunction and High-glucose-fat diet and streptozotocin-induced diabetic nephropathy rats. Zhang MH; Feng L; Zhu MM; Gu JF; Jiang J; Cheng XD; Ding SM; Wu C; Jia XB J Ethnopharmacol; 2014; 151(1):591-600. PubMed ID: 24269777 [TBL] [Abstract][Full Text] [Related]
6. Quercetin ameliorates diabetic nephropathy by reducing the expressions of transforming growth factor-β1 and connective tissue growth factor in streptozotocin-induced diabetic rats. Lai PB; Zhang L; Yang LY Ren Fail; 2012; 34(1):83-7. PubMed ID: 22011322 [TBL] [Abstract][Full Text] [Related]
7. Mycophenolate mofetil ameliorates diabetic nephropathy through epithelial mesenchymal transition in rats. Xiao X; Wang J; Chang X; Zhen J; Zhou G; Hu Z Mol Med Rep; 2015 Sep; 12(3):4043-4050. PubMed ID: 26080907 [TBL] [Abstract][Full Text] [Related]
8. Huangkui capsule attenuates renal fibrosis in diabetic nephropathy rats through regulating oxidative stress and p38MAPK/Akt pathways, compared to α-lipoic acid. Mao ZM; Shen SM; Wan YG; Sun W; Chen HL; Huang MM; Yang JJ; Wu W; Tang HT; Tang RM J Ethnopharmacol; 2015 Sep; 173():256-65. PubMed ID: 26226437 [TBL] [Abstract][Full Text] [Related]
9. Protective effects of leflunomide on renal lesions in a rat model if diabetic nephropathy. Zhang Q; Ji Y; Lv W; He T; Wang J Ren Fail; 2016; 38(1):124-30. PubMed ID: 26512931 [TBL] [Abstract][Full Text] [Related]
10. Effects of mycophenolate mofetil, valsartan and their combined therapy on preventing podocyte loss in early stage of diabetic nephropathy in rats. Zhang Y; Chen B; Hou XH; Guan GJ; Liu G; Liu HY; Li XG Chin Med J (Engl); 2007 Jun; 120(11):988-95. PubMed ID: 17624267 [TBL] [Abstract][Full Text] [Related]
11. Prevention of early renal injury by mycophenolate mofetil and its mechanism in experimental diabetes. Wu YG; Lin H; Qi XM; Wu GZ; Qian H; Zhao M; Shen JJ; Lin ST Int Immunopharmacol; 2006 Mar; 6(3):445-53. PubMed ID: 16428080 [TBL] [Abstract][Full Text] [Related]
12. Combined therapy of rhein and benazepril on the treatment of diabetic nephropathy in db/db mice. Jia ZH; Liu ZH; Zheng JM; Zeng CH; Li LS Exp Clin Endocrinol Diabetes; 2007 Oct; 115(9):571-6. PubMed ID: 17943690 [TBL] [Abstract][Full Text] [Related]
13. Superior renoprotective effects of the combination of breviscapine with enalapril and its mechanism in diabetic rats. Xu XX; Zhang W; Zhang P; Qi XM; Wu YG; Shen JJ Phytomedicine; 2013 Jul; 20(10):820-7. PubMed ID: 23664882 [TBL] [Abstract][Full Text] [Related]
14. Suppression of transforming growth factor-beta1 gene expression by Danggui buxue tang, a traditional Chinese herbal preparation, in retarding the progress of renal damage in streptozotocin-induced diabetic rats. Zhang YW; Xie D; Xia B; Zhen RT; Liu IM; Cheng JT Horm Metab Res; 2006 Feb; 38(2):82-8. PubMed ID: 16523407 [TBL] [Abstract][Full Text] [Related]
15. Effects of benazepril on renal function and kidney expression of matrix metalloproteinase-2 and tissue inhibitor of metalloproteinase-2 in diabetic rats. Sun SZ; Wang Y; Li Q; Tian YJ; Liu MH; Yu YH Chin Med J (Engl); 2006 May; 119(10):814-21. PubMed ID: 16732983 [TBL] [Abstract][Full Text] [Related]
16. Attenuation of diabetic nephropathy by Chaihuang-Yishen granule through anti-inflammatory mechanism in streptozotocin-induced rat model of diabetics. Zhang H; Zhao T; Gong Y; Dong X; Zhang W; Sun S; Wang H; Gu Y; Lu X; Yan M; Li P J Ethnopharmacol; 2014; 151(1):556-64. PubMed ID: 24269779 [TBL] [Abstract][Full Text] [Related]
17. Renoprotective effects of combination of angiotensin converting enzyme inhibitor with mycophenolate mofetil in diabetic rats. Wu YG; Lin H; Qian H; Zhao M; Qi XM; Wu GZ; Lin ST Inflamm Res; 2006 May; 55(5):192-9. PubMed ID: 16830106 [TBL] [Abstract][Full Text] [Related]
18. Bergenin ameliorates diabetic nephropathy in rats via suppressing renal inflammation and TGF-β1-Smads pathway. Yang J; Kan M; Wu GY Immunopharmacol Immunotoxicol; 2016; 38(2):145-52. PubMed ID: 26954391 [TBL] [Abstract][Full Text] [Related]
19. Protective role of low-dose TGF-β1 in early diabetic nephropathy induced by streptozotocin. Ma X; Ding J; Min H; Wen Y; Gao Q Int Immunopharmacol; 2013 Nov; 17(3):752-8. PubMed ID: 24055008 [TBL] [Abstract][Full Text] [Related]
20. [Effect of treatment in 39 patients with diabetic nephropathy by safflor yellow and benazepril in combination]. Guo DZ; Wang YH; Chen ZQ Zhongguo Zhong Xi Yi Jie He Za Zhi; 2008 Apr; 28(4):360-3. PubMed ID: 18543495 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]